Difficult to treat infections and antimicrobians use

Oscar Murillo Rubio

PRINCIPAL INVESTIGATORS
  • María Del Carmen Cabellos Mínguez
  • Javier Ariza Cardenal
CLINICAL RESEARCHERS
  • Eva Benavent Palomares
  • Francisco Javier Cabo Cabo
  • Fe Tubau Quintano
  • Raül Rigo Bonnin
  • Laura Soldevila Boixader
POSTDOCTORAL RESEARCHERS
  • Cristina El Haj Hidalgo
PREDOCTORAL RESEARCHERS
  • Eva Benavent Palomares
SCIENTIFIC SUPPORT
  • Maria Eugenia Agusti Carol
Translational Medicine
Infectious disease and transplantation

Scientific production

29

PAPERS

Average IF: 5,79

22

LED PAPERS

Average IF: 5,7

4 PUBLICATIONS IN FIRST DECILE

19 PUBLICATIONS IN FIRST QUARTILE

21 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Pérez Galera,S;Bravo Ferrer,JM;Paniagua,M;Kostyanev,T;de Kraker,M;Feifel,J;Sojo Dorado,J et al, Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)., EClinicalMedicine, 2023;57101871-101871, doi:10.1016/j.eclinm.2023.101871
  • Saiz Escobedo,L;Cadenas Jiménez,I;Olmos,R;Carrera Salinas,A;Berbel,D;Càmara,J;Tubau,F et al, Detection of blaCTX-M-15 in an integrative and conjugative element in four extensively drug-resistant Haemophilus parainfluenzae strains causing urethritis, Int. J. Antimicrob. Agents, 2023;62(5):106991-106991, doi:10.1016/j.ijantimicag.2023.106991
  • Benavent,E;Ulldemolins,M;El Haj,C;Rigo Bonnin,R;Yu,HD;Wang,LY;Wickremasinghe,H et al, Efficacy of meropenem extended infusion vs intermittent bolus monotherapy and in combination with colistin against Pseudomonas aeruginosa biofilm, Int. J. Antimicrob. Agents, 2023;62(2):106856-106856, doi:10.1016/j.ijantimicag.2023.106856
  • Lloberas,N;Grinyó,JM;Colom,H;Vidal Alabró,A;Fontova,P;Rigo Bonnin,R;Padró,A et al, A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction, Kidney Int., 2023;104(4):840-850, doi:10.1016/j.kint.2023.06.021
  • Benavent,E;Kortajarena,X;Sobrino Diaz,B;Gasch,O;Rodríguez Pardo,D;Escudero Sanchez,R;Bahamonde,A et al, Vertebral osteomyelitis after spine instrumentation surgery: risk factors and management, J. Hosp. Infect., 2023;140102-109, doi:10.1016/j.jhin.2023.07.008

Research highlights

PROJECTS

1 Granted competitive project
4 Ongoing competitive projects

1 Started clinical trial
3 Ongoing clinical trials
1 Ongoing non competitive project

PUBLISHED WORKS

1 Thesis
1 Clinical guideline

NETWORKS

CIBER-INFEC
AGAUR-SGR GRC
CSUR

Selected projects

  • FIS23016. Problemática de la infección asociada a biofilms de P. aeruginosa XDR/DTR: evaluación de alternativas terapéuticas y de su impacto en la estructura del biofilm y el resistoma. Instituto de Salud Carlos III (ISCIII). Budget: 141.250€. 2024-2026. PI: Murillo Rubio, Oscar.
  • 19FIS018. Vasculitis cerebral post meningitis neumocócica: Factores relacionados y etiopatogenia. Instituto de Salud Carlos III (ISCIII). Budget: 111.320€. 2019-2023. PI: Cabellos Mínguez, María del Carmen.
  • 19MEC020. AYUDAS PARA LA FORMACION DE DOCTORES DEL PROGRAMA NACIONAL DE FORMACION DE PROFESORADO UNIVERSITARIO (FPU). MINISTERIO DE EDUCACIÓN Y FORMACIÓN PROFESIONAL. Budget: 81.493,77€. 2019-2023. PI: Murillo Rubio, Oscar.
  • 20FIS009. Optimizing the treatment with beta-lactams against biofilm-related infections caused by Gramnegative bacilli: the need for redefining their pharmacodynamics. Instituto de Salud Carlos III (ISCIII). Budget: 49.610€. 2020-2023. PI: Murillo Rubio, Oscar.
  • 20FIS006. Impacto de un programa de antibióticos con acceso a expertos en enfermedades infecciosas en atención primaria: Estudio controlado no ciego con aleatorización por conglomerados (PROAP). Instituto de Salud Carlos III (ISCIII). Budget: 24.200€. 2020-2023. PI: Shaw Perujo, Evelyn.